Endogenous BMP-7 is a critical molecular determinant of the reversibility of obstruction-induced renal injuries

American Journal of Physiology - Renal Physiology

Volumn 301, Issue 6, 2011, Pages

  Manson, Scott R ^a   Niederhoff, Robert A ^a   Hruska, Keith A ^b   Austin, Paul F ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

Bone morphogenic protein 7; Fibrosis; Kidney; Smad proteins; Ureteral obstruction

Indexed keywords

NEUTRALIZING ANTIBODY; OSTEOGENIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; KIDNEY FIBROSIS; KIDNEY INJURY; MOUSE; NONHUMAN; OBSTRUCTIVE UROPATHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; URETER OBSTRUCTION;

EID: 82755191630     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00071.2011     Document Type: Article

References (28)

1. Biyikli NK, Tugtepe H, Cakalagaoglu F, Ilki A, Alpay H. Downregulation of the expression of bone morphogenetic protein 7 in experimental pyelonephritis. Pediatr Nephrol 20: 1230-1236, 2005.
2. Bottinger EP. TGF-beta in renal injury and disease. Semin Nephrol 27: 309-320, 2007.
3. Chevalier RL. Obstructive nephropathy: towards biomarker discovery and gene therapy. Nat Clin Pract 2: 157-168, 2006.
4. Chevalier RL. Pathogenesis of renal injury in obstructive uropathy. Curr Opin Pediatr 18: 153-160, 2006.
5. Cochrane AL, Kett MM, Samuel CS, Campanale NV, Anderson WP, Hume DA, Little MH, Bertram JF, Ricardo SD. Renal structural and functional repair in a mouse model of reversal of ureteral obstruction. J Am Soc Nephrol 16: 3623-3630, 2005.
6. Gagliardini E, Benigni A. Role of anti-TGF-beta antibodies in the treatment of renal injury. Cytokine Growth Factor Rev 17: 89-96, 2006.
7. Hautmann MB, Madsen CS, Owens GK. A transforming growth factor beta (TGFbeta) control element drives TGFbeta-induced stimulation of smooth muscle alpha-actin gene expression in concert with two CArG elements. J Biol Chem 272: 10948-10956, 1997.
8. Hruska KA, Guo G, Wozniak M, Martin D, Miller S, Liapis H, Loveday K, Klahr S, Sampath TK, Morrissey J. Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am J Physiol Renal Physiol 279: F130-F143, 2000.
9. Humphreys BD, Bonventre JV. Mesenchymal stem cells in acute kidney injury. Annu Rev Med 59: 311-325, 2008.
10. Humphreys BD, Valerius MT, Kobayashi A, Mugford JW, Soeung S, Duffield JS, McMahon AP, Bonventre JV. Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2: 284-291, 2008.
11. Isaka Y, Tsujie M, Ando Y, Nakamura H, Kaneda Y, Imai E, Hori M. Transforming growth factor-beta 1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction. Kidney Int 58: 1885-1892, 2000.
12. Ishibe S, Cantley LG. Epithelial-mesenchymal-epithelial cycling in kidney repair. Curr Opin Nephrol Hypertens 17: 379-385, 2008.
13. Little MH. Regrow or repair: potential regenerative therapies for the kidney. J Am Soc Nephrol 17: 2390-2401, 2006.
14. Manson SRNR, Hruska KA, Austin PF. The BMP-7-Smad1/5/8 pathway promotes the repair of the kidney following obstruction-induced renal injury. J Urol 185: 2523-2530, 2011.
15. Miyajima A, Chen J, Lawrence C, Ledbetter S, Soslow RA, Stern J, Jha S, Pigato J, Lemer ML, Poppas DP, Vaughan ED, Felsen D. Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int 58: 2301-2313, 2000.
16. Miyazono K, Kusanagi K, Inoue H. Divergence and convergence of TGF-beta/BMP signaling. J Cell Physiol 187: 265-276, 2001.
17. Morrissey J, Hruska K, Guo G, Wang S, Chen Q, Klahr S. Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function. J Am Soc Nephrol 13, Suppl 1: S14-S21, 2002.
18. Neild GH. Primary renal disease in young adults with renal failure. Nephrol Dial Transplant 25: 1025-1032, 2010.
19. Patel SR, Dressler GR. BMP7 signaling in renal development and disease. Trends Mol Med 11: 512-518, 2005.
20. Ritzenthaler JD, Goldstein RH, Fine A, Smith BD. Regulation of the alpha 1(I) collagen promoter via a transforming growth factor-beta activation element. J Biol Chem 268: 13625-13631, 1993.
21. Samuel CS. Determination of collagen content, concentration, and subtypes in kidney tissue. Methods Mol Biol 466: 223-235, 2009.
22. Simon M, Maresh JG, Harris SE, Hernandez JD, Arar M, Olson MS, Abboud HE. Expression of bone morphogenetic protein-7 mRNA in normal and ischemic adult rat kidney. Am J Physiol Renal Physiol 276: F382-F389, 1999.
23. Tuglular S, Gogas Yavuz D, Cakalagaoglu F, Citak L, Arikan H, Kocak H, Ozener C, Akoglu E. Cyclosporine-A induced nephrotoxicity is associated with decreased renal bone morphogenetic protein-7 expression in rats. Transplant Proc 36: 131-133, 2004.
24. Wang S, de Caestecker M, Kopp J, Mitu G, Lapage J, Hirschberg R. Renal bone morphogenetic protein-7 protects against diabetic nephropathy. J Am Soc Nephrol 17: 2504-2512, 2006.
25. Yanagita M, Okuda T, Endo S, Tanaka M, Takahashi K, Sugiyama F, Kunita S, Takahashi S, Fukatsu A, Yanagisawa M, Kita T, Sakurai T. Uterine sensitization-associated gene-1 (USAG-1), a novel BMP antagonist expressed in the kidney, accelerates tubular injury. J Clin Invest 116: 70-79, 2006.
26. Zeisberg M, Bottiglio C, Kumar N, Maeshima Y, Strutz F, Muller GA, Kalluri R. Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am J Physiol Renal Physiol 285: F1060-F1067, 2003.
27. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 9: 964-968, 2003.
28. Zeisberg M, Shah AA, Kalluri R. Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J Biol Chem 280: 8094-8100, 2005.